The PLOD1 gene helps your body strengthen collagen, a key material in skin, joints, blood vessels, and other connective tissues. What this gene does can influence how your body holds tissues together. If it does not work properly, collagen is built less securely, which can lead to very flexible joints, fragile or stretchy skin, muscle weakness, easy bruising, and spinal curvature. Pathogenic variants in the PLOD1 gene are a known cause of kyphoscoliotic Ehlers-Danlos syndrome, a connective tissue condition that often starts early in life.
What is a gene?
A gene is a section of DNA that carries information cells can use to make molecules or regulate processes in the body. Some genes provide the instructions for producing proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they take place, and how strongly they operate. In combination, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
PLOD1Gene function
What if the gene works
The PLOD1 gene helps your body build strong collagen, a protein that supports skin, joints, blood vessels, and other connective tissues. This helps tissues stay stable and handle everyday strain.
Risk
What if the gene does not work
More severe variants in the PLOD1 gene can cause kyphoscoliotic Ehlers-Danlos syndrome, with low muscle tone, early spinal curvature, very flexible joints, and fragile skin and tissues. Milder variants may cause a later start or less marked features.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the PLOD1 gene, no PLOD1-specific treatment or drug-selection approach is currently established, and care is based on a person’s symptoms rather than on a gene-directed therapy.
Conditions associated with PLOD1
Gene function
What if the gene works
Your body uses the PLOD1 gene while building collagen, the main protein that supports skin, joints, bones, and blood vessels. It helps newly made collagen go through an important finishing step inside cells. Understanding PLOD1 gene function helps explain how collagen gets the right strength and stretch for everyday movement.
Inside cells, the PLOD1 gene helps prepare newly made collagen before it is sent out of the cell. It adds a small chemical tag to selected building blocks, which is an important step in collagen processing.
This finishing step helps collagen molecules connect to each other in a controlled way. Those links give tissues steady strength and flexibility during stretching, bending, and everyday movement.
Well-prepared collagen helps skin, ligaments, bones, and blood vessel walls keep their structure. This is part of how the PLOD1 gene helps build collagen that supports tissues throughout the body.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PLOD1 gene can change how much working protein the cell makes or how well that protein functions, which is how PLOD1 gene variants affect collagen processing. Some variants leave a protein that is unstable or has reduced activity, while more disruptive variants may stop the protein from being made at all. This spectrum can lead to milder or stronger effects at the tissue level and, in people with kyphoscoliotic Ehlers-Danlos syndrome, may influence how early and how noticeably features appear.
How variants are linked to conditions
Pathogenic variants in the PLOD1 gene are linked to kyphoscoliotic Ehlers-Danlos syndrome and can confirm this rare inherited diagnosis when both gene copies are affected. People with this condition often have very flexible joints, low muscle tone from infancy, and early spinal curvature that may worsen over time. Carrying one pathogenic variant usually means a person is a carrier rather than having the condition.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of being human and are widely found in the general population. Most do not have a direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, however, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PLOD1-related illness, risk is mainly set by inheritance, not by lifestyle. A child is affected only if they inherit two changed copies of the PLOD1 gene, one from each parent, so family history and having a partner who also carries a PLOD1 variant raise the chance of an affected pregnancy.
Inheritance of PLOD1 variants
PLOD1-related conditions are inherited in an autosomal recessive pattern. For families asking how PLOD1 gene variants are inherited, this usually means a person has to inherit two altered copies of the PLOD1 gene, one from each parent, to have the condition. Parents who each carry one variant are usually unaffected carriers. With each pregnancy, two carrier parents have a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variants.
What does my PLOD1 result mean for my family?
For PLOD1, family meaning usually follows a recessive pattern linked to kyphoscoliotic Ehlers-Danlos syndrome, a condition that affects connective tissue. Brothers and sisters may also have the condition or be carriers, even if they seem well. Parents are often healthy carriers, and other relatives on the same side of the family may be carriers too. Children of someone with a PLOD1-related condition are usually carriers unless the other parent also carries a changed PLOD1 gene.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the PLOD1 gene, genetic testing uses DNA from blood, saliva, or a cheek swab. The lab reads the gene's code and looks for changes linked with kyphoscoliotic Ehlers-Danlos syndrome. A PLOD1 gene test for kyphoscoliotic Ehlers-Danlos syndrome can help confirm the diagnosis.
When should I consider getting a genetic test?
Genetic testing for the PLOD1 gene may be worth considering when someone has signs of a rare inherited condition that affects connective tissues, known medically as kyphoscoliotic Ehlers-Danlos syndrome. Clues can include very flexible joints, early spine curvature, weak muscles from infancy, and skin that bruises or tears easily, or a close family member with a known PLOD1 variant.
A genetic result is only one part of your health story
Genetic findings can offer useful insight, but how much they reveal varies depending on the condition and the type of variant involved. Over time, factors such as lifestyle, environment, age, and medical history also influence how the body works. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. For medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it through the bloodstream, or responds to its effects. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people. These differences are common and can influence both how effective a medicine feels and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes can affect the way people respond to medicines. It examines links between genes and medications to help explain why the same treatment may not work the same way for everyone. With many drugs, genes can influence either how strongly a medicine works or how the body handles it. This information can support better informed, more personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the PLOD1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have side effects, concerns about a new medicine, or questions about how treatment fits your health history, talk with your doctor or pharmacist.